Aging Clinical and Experimental Research

, Volume 25, Issue 5, pp 605–609 | Cite as

Bisphosphonate long-term treatment related bilateral subtrochanteric femoral fracture. Can teriparatide be useful?

  • Francisco José Tarazona-Santabalbina
  • Luis Aguilella-Fernández
Case Report


Long-term treatment with biphosphonates has been related to atypical femoral fractures. We report the clinical case of a woman who suffered a proximal diaphyseal oblique fracture of the left femur after uninterrupted 13-year treatment with alendronate. Shortly after surgery, a painful lytic image in the external cortex of her right femur diaphysis was detected. Some papers have suggested surgical treatment to repair femur fractures after long-term treatment with bisphosphonates. Otherwise, two studies have shown healing acceleration of bone fractures with teriparatide. A lytic lesion was treated with teriparatide obtaining progressive disappearance of symptoms as well as bone healing. This outcome may suggest a way of prevention of complete fractures in symptomatic patients with long-term treatment with bisphosphonates.


Hip fracture Bisphosphonates Long-term treatment 


Conflict of interest

The authors declare that they have no conflict of interest related to the publication of this manuscript.


  1. 1.
    Kleerekoper M (2005) Prevention of postmenopausal bone loss and treatment of osteoporosis. Semin Reprod Med 23:141–148PubMedCrossRefGoogle Scholar
  2. 2.
    Neviaser AS, Lane JM, Lenart BA, Edobor-Osula F, Lorich DG (2008) Low-energy femoral shaft fractures associated with alendronate use. J Orthop Trauma 22:346–350PubMedCrossRefGoogle Scholar
  3. 3.
    Black D, Schwartz A, Ensrud K, Rybak-Feiglin A, Gupta J, Lombardi A, Wallace R, Levis S, Quandt S, Satterfield S, Cauley J, Cummings S (2004) A 5 year randomized trial of the long-term efficacy and safety of alendronate. J Bone Miner Res 10:S45Google Scholar
  4. 4.
    Bone HG, Schurr W (2004) Intravenous bisphosphonate therapy for osteoporosis: where do we stand? Curr Osteoporos Rep 2:24–30PubMedCrossRefGoogle Scholar
  5. 5.
    Tonino RP, Meunier PJ, Emkey R, Rodriguez-Portales JA, Menkes CJ, Wasnich RD, Bone HG, Santora AC, Wu M, Desai R, Ross PD (2000) Skeletal benefits of alendronate: 7-year treatment of postmenopausal osteoporotic women. J Clin Endocrinol Metab 85:3109–3115PubMedCrossRefGoogle Scholar
  6. 6.
    Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, Bauer DC, Genant HK, Haskell WL, Marcus R, Ott SM, Torner JC, Quandt SA, Reiss TF, Ensrud KE (1996) Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet 348:1535–1541PubMedCrossRefGoogle Scholar
  7. 7.
    Neviaser AS, Lane JM, Lenart BA, Edobor-Osula F, Lorich DG (2008) Low-energy femoral shaft fractures associated with alendronate use. J Orthop Trauma 22:346–350PubMedCrossRefGoogle Scholar
  8. 8.
    Kennel KA, Matthew TD (2009) Adverse effects of bisphosphonates: implications for osteoporosis management. Mayo Clin Proc 84(7):632–638PubMedGoogle Scholar
  9. 9.
    Gates BJ, Sonnett TE, DuVall CAK, Dobbins EK (2009) Review of osteoporosis pharmacotherapy for geriatric patients. Am J Geriatr Pharmacother 7(6):293–322PubMedCrossRefGoogle Scholar
  10. 10.
    Cheung RKH, Leung KK, Lee KC, Chow TC (2007) Sequential non-traumatic femoral shaft fractures in a patient on long-term alendronate. Hong Kong Med J 13(6):485–489PubMedGoogle Scholar
  11. 11.
    Goh SK, Yang KY, Koh JSB et al (2007) Subtrochanteric insufficiency fractures in patients on alendronate therapy. A caution. J Bone Joint Surg Br 89(3):349–353PubMedGoogle Scholar
  12. 12.
    Kwek EBK, Goh SK, Koh JSB, Png MA, Howe TS (2008) An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy? Injury 39(2):224–231PubMedCrossRefGoogle Scholar
  13. 13.
    Lenart BA, Lorich DG, Lane JM (2008) Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate. N Engl J Med 358(12):1304–1306PubMedCrossRefGoogle Scholar
  14. 14.
    Sayed-Noor AS, Sjoden GO (2008) Subtrochanteric displaced insufficiency fracture after long term alendronate therapy—a case report. Acta Orthop 79(4):565–567PubMedCrossRefGoogle Scholar
  15. 15.
    Schneider JP (2006) Should bisphosphonates be continued indefinitely? An unusual fracture in a healthy woman on long-term alendronate. Geriatrics 61(1):31–33PubMedGoogle Scholar
  16. 16.
    Whyte MP (2009) Atypical femoral fractures, bisphosphonates, and adult hypophosphatasia. J Bone Miner Res 24(6):1132–1134PubMedCrossRefGoogle Scholar
  17. 17.
    Abrahamsen B, Eiken P, Eastell R (2009) Subtrochanteric and diaphyseal femur fractures in patients treated with alendronate: a register-based national cohort study. J Bone Miner Res 24(6):1095–1102PubMedCrossRefGoogle Scholar
  18. 18.
    Odvina CV, Zerwekh JE, Rao DS, Maalouf N, Gottschalk FA, Pak CY (2005) Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab 90:1294–1301PubMedCrossRefGoogle Scholar
  19. 19.
    Sayed-Noor AS, Sjödén GO (2009) Two femoral insufficiency fractures after long-term alendronate therapy. Clin Orthop Relat Res 467:1921–1926PubMedCrossRefGoogle Scholar
  20. 20.
    Visekruna M, Wilson D, McKiernan FE (2008) Severely suppressed bone turnover and atypical skeletal fragility. J Clin Endocrinol Metab 93(8):2948–2952PubMedCrossRefGoogle Scholar
  21. 21.
    Khan SA, Kanis JA, Vasikaran S et al (1997) Elimination and biochemical responses to intravenous alendronate in postmenopausal osteoporosis. J Bone Miner Res 12(10):1700–1707PubMedCrossRefGoogle Scholar
  22. 22.
    Ensrud KE, Barrett-Connor EL, Schwartz A et al (2004) Randomized trial of effect of alendronate continuation versus discontinuation in women with low BMD: results from the fracture intervention trial long-term extension. J Bone Miner Res 19(8):1259–1269PubMedCrossRefGoogle Scholar
  23. 23.
    Rodan G, Reszka A, Golub E, Rizzoli R (2004) Bone safety of long-term bisphosphonate treatment. Curr Med Res Opin 20(8):1291–1300PubMedCrossRefGoogle Scholar
  24. 24.
    Goddard MS, Reid KR, Johnston JC, Khanuja HS (2009) Atraumatic bilateral femur fracture in long-term bisphosphonate use. Orthopedics 32(8):607–610CrossRefGoogle Scholar
  25. 25.
    Bamrungsong T, Pongchaiyakul Ch (2010) Bilateral atypical femoral fractures after long-term alendronate therapy: a case report. J Med Assoc Thai 93(5):620–624PubMedGoogle Scholar
  26. 26.
    Gunawardena I, Baxter M, Rasekh Y (2001) Bisphosphonate-related subtrochanteric femoral fractures. Am J Geriatr Pharmacother 9(3):194–198CrossRefGoogle Scholar
  27. 27.
    Nieves JW, Cosman F (2010) Atypical subtrochanteric and femoral shaft fractures and possible association with bisphosphonates. Curr Osteoporos Rep 8:34–39PubMedCrossRefGoogle Scholar
  28. 28.
    Resmini G, Iolascon G (2011) New insights into the role of teriparatide. Aging Clin Exp Res 23(2):30–32PubMedGoogle Scholar
  29. 29.
    Mognetti B, Marino S, Barberis A, Martin AS, Bala Y, Di Carlo F, Boivin G, Basbos MP (2011) Experimental stimulation of bone healing with teriparatide: histomorphometric and microhardness analysis in a mouse model of closed fracture. Calcif Tissue Int 89(2):163–171PubMedCrossRefGoogle Scholar
  30. 30.
    Komrakoya M, Stuermer EK, Werner C, Wicke M, Kolios L, Shmisch S, Tezval M, Daub F, Martens T, Witzenhausen P, Dullin C, Sturmer KM (2010) Effect of human parathyroid hormone hPTH (1-34) applied at different regimes on fracture healing and muscle in ovariectomized and healthy rats. Bone 47(3):480–492CrossRefGoogle Scholar
  31. 31.
    Ott SM (2005) Editorial: long-term safety of bisphosphonates. J Clin Endocrinol Metab 90(3):1897–1899PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2013

Authors and Affiliations

  • Francisco José Tarazona-Santabalbina
    • 1
  • Luis Aguilella-Fernández
    • 2
  1. 1.Geriatric Medicine DeparmentHospital Universitario de la RiberaAlziraSpain
  2. 2.Orthopaedics DepartmentHospital Universitario de la RiberaAlziraSpain

Personalised recommendations